Role of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
9 months agoRole of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
9 months ago
What Does an Oncologist Do? A Comprehensive Guide to Their Role in Cancer Treatment
If you or someone you care about has been diagnosed with cancer, you're likely to come across the term "oncologist." But what exactly is an oncologist, and what do they do? In this article, we'll delve into the world of...
9 months agoWhat Does an Oncologist Do? A Comprehensive Guide to Their Role in Cancer Treatment
If you or someone you care about has been diagnosed with cancer, you're likely to come across the term "oncologist." But what exactly is an oncologist, and what do they do? In this article, we'll delve into the world of...
9 months ago
Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets
Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...
3 years agoIntrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets
Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...
3 years ago
The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors
Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...
3 years agoThe Latest Advancements in Immuno-oncology: Checkpoint Inhibitors
Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...
3 years ago
Protein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
3 years agoProtein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
3 years ago
Aseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
3 years agoAseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
3 years ago
Another Direction for Clinical Oncology: Targeting the Anti-Inflammatory Response in Cancer
Approximately 15-20% of all cancer cases are preceded by infection, chronic inflammation, or autoimmunity at the same tissue or organ site. While inflammation is a natural response to tissue damage, chronic inflammation can become pathological. The role of inflammation in...
3 years agoAnother Direction for Clinical Oncology: Targeting the Anti-Inflammatory Response in Cancer
Approximately 15-20% of all cancer cases are preceded by infection, chronic inflammation, or autoimmunity at the same tissue or organ site. While inflammation is a natural response to tissue damage, chronic inflammation can become pathological. The role of inflammation in...
3 years ago
How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
3 years agoHow Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
3 years ago
Biomarker Discovery and Validation: Current Challenges in Oncology
Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...
3 years agoBiomarker Discovery and Validation: Current Challenges in Oncology
Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...
3 years ago
The Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years agoThe Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years ago